Caladrix is a CNS-focused biotechnology company pioneering disease-modifying therapeutics for Alzheimer’s and related tauopathies. Founded in 2025, our mission is to harness the brain’s intrinsic clearance pathways—starting with ABCC1, a genetically validated efflux transporter that exports neurotox...See more
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2025 (1 years)
Address:
MELBOURNE, AU
Employees by Department
- The Rest (1)
- Total (1)
Key Decision Makers
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has CALADRIX been operating for?
- What is the funding status of CALADRIX?
- Where is CALADRIX's headquarter?
- What CALADRIX's spending power?
- Does CALADRIX have a presence in the domain it operates in?

